Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Journal of Nephrology|December 14, 2004
Association between transforming growth factor beta1 gene polymorphisms and IgA nephropathySonia Carturan, Dario Roccatello, Elisa Menegatti, et al.
Autoimmunity Reviews|December 11, 2012
Lab-on-a-chip: emerging analytical platforms for immune-mediated diseasesElisa Menegatti, Daniela Berardi, Margherita Messina, et al.
International Journal of Cardiology|June 17, 2022
Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-headAlice Barinotti, Massimo Radin, Irene Cecchi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 10, 2011
Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapyDario Roccatello, Savino Sciascia, Daniela Rossi, et al.
Clinical and Molecular Allergy : CMA|July 19, 2016
Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assaySavino Sciascia, Simone Baldovino, Karen Schreiber, et al.
Autoimmunity Reviews|September 16, 2018
Neutrophils: Novel key players in Rheumatoid Arthritis. Current and future therapeutic targetsIrene Cecchi, Ivan Arias de la Rosa, Elisa Menegatti, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 11, 2002
Polymorphism of the uteroglobin gene in systemic lupus erythematosus and IgA nephropathyElisa Menegatti, Antonella Nardacchione, Mirella Alpa, et al.
Autoimmunity Reviews|August 6, 2015
A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessmentDario Roccatello, Savino Sciascia, Simone Baldovino, et al.
The International Journal of Biological Markers|April 4, 2015
Possible role for interleukins as biomarkers for mortality and recurrence in oral cancerPaolo G Arduino, Elisa Menegatti, Nazario Cappello, et al.
Clinical and Experimental Rheumatology|October 28, 2022
Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocolSavino Sciascia, Massimo Radin, Irene Cecchi, et al.
Pageof 6